Anaplastic Large Cells Lymphoma (ALCL) ALK+ research hub

A PHASE 2 OPEN LABEL STUDY OF ORAL LORLATINIB (PF-06463922) IN PATIENTS WITH RELAPSED ALK POSITIVE LYMPHOMA PREVIOUSLY TREATED WITH ALK INHIBITORS

This study is looking at a new drug called Lorviqua for adults with a type of lymphoma called ALCL. It's for people whose ALCL has come back after other treatments and is trying to see if Lorviqua can shrink the cancer.